Alternatives to BizNet

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

Medrio's Electronic Data Capture (EDC) platform and complimenting eClinical solutions such as ePRO, RTSM, eConsent, and Direct Data Capture (DDC) have been trusted by major pharmaceutical, biotech, CRO, animal health, medical device, and diagnostic companies since 2005. We are known for our easy-to-use solutions, delivering speed and simplicity to clinical trials of all phases, sizes, and complexities. Medrio users can build their databases in an average of 2.8 weeks with no programming required, make mid-study changes with just a few clicks of a mouse, and much more. From bolt-on capabilities to full-service offerings, Medrio offers flexible, modular solutions that give our customers exactly what they need – and none of what they don’t. Our innovative software, as well as the robust and flexible training and support resources we provide our customers, have earned us a 98% customer satisfaction rating.

The TCS ADD platform significantly enhances the speed at which pharmaceutical companies can bring products to market by streamlining the entire clinical research and development process, ultimately leading to more agile and secure clinical trials. By fostering digital ecosystems and simplifying the intricacies of data management, TCS ADD facilitates quicker access to innovative and effective medications for patients. This platform utilizes the TCS Decision FabricTM, an advanced cognitive artificial intelligence engine, alongside smart analytics and the Internet of Things, delivering exceptional business advantages to the pharmaceutical sector. It serves as a comprehensive, metadata-driven solution designed to uphold industry standards and sponsor requirements in clinical trials. Furthermore, this data science-oriented platform employs artificial intelligence and machine learning technologies to expedite decision-making, accelerate study initiation, and implement targeted interventions. By digitizing the entire supply chain management of clinical trials while prioritizing patient safety, this solution not only improves overall effectiveness but also enhances the patient experience throughout the trial process. Ultimately, TCS ADD represents a transformative approach to clinical trial management that aligns with the evolving needs of healthcare.

Our approach to supporting your team begins with our innovative, multi-faceted platform. Clinical StudyPal is a comprehensive, customizable, and patient-focused technology that streamlines your research processes, making them quicker, simpler, and more economical. As a mobile application, it fosters collaboration and enhances engagement between sites and patients, while its web interface allows for effective study management through robust analytics. Additionally, as a notification system, it ensures that both your patients and study team are consistently informed. What benefits can Clinical StudyPal offer your organization? The more pertinent inquiry might be, what limitations does it have? With our cutting-edge technology and commitment to patient-centric solutions, our dedicated team is eager to assist yours in creating a seamless and successful trial experience tailored to your needs. Ultimately, our goal is to empower your research endeavors in every possible way.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

Science 37 is a pioneering clinical research organization that focuses on decentralized clinical trials through its innovative Metasite model, which eliminates the need for physical proximity, allowing patients to engage in studies from virtually anywhere. This method significantly broadens accessibility, reaching over 90% of individuals who might be excluded from conventional site-based research, and harnesses the recruiting capabilities equivalent to 20 sites in one location, thereby offering patients the flexibility they desire. The Metasite operates on a proprietary platform that not only streamlines study orchestration but also facilitates the workflow for both patients and research staff, all while efficiently capturing study data without manual reentry. By centralizing personnel, processes, and technologies, this approach guarantees built-in protocol compliance, which leads to enhanced compliance rates and the collection of high-quality data. Science 37's dedicated in-house medical teams, telemedicine investigators, and mobile nursing professionals are well-versed in the conduct of remote trials spanning various therapeutic areas, thus ensuring comprehensive outreach. This commitment to innovative trial methodologies positions Science 37 at the forefront of transforming the landscape of clinical research.

Zelta is a cloud-powered platform for unified clinical data management and acquisition, designed to streamline and enhance clinical trial processes. Its modular architecture adapts to the unique demands of each study, enabling faster and more efficient outcomes. With capabilities such as electronic data capture, clinical operations management—including randomization and trial supply tracking—clinical trial management, and electronic trial master file functionality, Zelta supports comprehensive study oversight. It also enhances patient and provider engagement with electronic clinical outcome assessments and e-consent solutions. Built for studies across all phases, therapeutic areas, and global regions, Zelta offers an intuitive user experience with secure single sign-on access from anywhere. Its flexible and scalable design allows for seamless customization and integration with both native and third-party technologies, ensuring adaptability to diverse research needs.

Uncover the most cutting-edge methods in the realm of clinical and patient-reported outcomes data. Our comprehensive solution transcends mere data entry, facilitating a genuinely patient-focused research experience. While our eCOA software is deeply rooted in principles of behavioral science, it has also been designed specifically by healthcare professionals to align with the needs of both sites and sponsors. By emphasizing personal identity, motivational intervals, and significant objectives, we stand out from other eCOA solutions. The Datacubed app features a user-friendly interface that allows participants to quickly engage with what truly matters. It has been highlighted that gathering data is now more straightforward than ever, thanks to our adaptable, user-friendly, and interactive application. As the need for flexibility in trial design continues to grow, we provide versatile data collection options that can be executed in person, remotely, or as a hybrid approach, catering to the diverse requirements of traditional, hybrid, and virtual clinical trials. This adaptability ensures that researchers can effectively capture the most relevant data, regardless of the study format.

In recent years, the Life Sciences sector has incurred nearly $15 billion in fines and settlements related to compliance, underscoring the importance for firms to follow best practices in pharmaceuticals, medical devices, and biotechnology. Additionally, the way clinical trials are managed can greatly influence the timeline, scope, and financial resources allocated for the development of drugs or medical devices. Utilizing OpenText™ Clinical Trial Quality Management System (ctQMS) allows organizations to maintain compliance, lower record management expenses, and foster collaboration to implement best practices throughout the entire clinical trial lifecycle. This strategic approach not only enhances operational efficiency but also contributes to the overall success of product development initiatives.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

Phoenix CTMS is a comprehensive, web-based clinical research platform that integrates Patient Recruitment System (PRS), Clinical Trial Management System (CTMS), and Clinical Data Management System (CDMS) capabilities into a single modular solution. The platform is designed to address the full spectrum of operational and regulatory demands faced by academic researchers, CROs, and hospitals running clinical trials at any phase. Phoenix CTMS provides a secure, private registry for sensitive patient data, ensuring compliance with EU-GDPR and other data privacy regulations. It supports a highly flexible electronic data capture (EDC) system with unlimited JavaScript form scripting for both server and browser, making it ideal for managing complex and large electronic case report forms (eCRFs). Users can conduct parallel trials while efficiently organizing site staff and resources through an intuitive interface. Unlike many commercial EDC packages, Phoenix CTMS is an open source project under LGPL 2.1, developed in collaboration with clinical trial sites at the Medical University of Graz. It is designed as a turnkey system that is operational out-of-the-box, eliminating the need for integrating multiple disparate tools. The platform is particularly suitable for users seeking a secure, private, and customizable clinical trial management solution.

Mahalo Health is an integrated digital health platform aimed at expediting the creation of patient-focused digital health solutions and clinical trials. By providing a variety of prebuilt modules, Mahalo facilitates the swift launch of customizable white-label applications that cater to particular therapeutic fields. The platform boasts comprehensive data capabilities, featuring a predictive health engine for forecasting diseases and diagnoses, a behavior modification engine to encourage beneficial patient behaviors, and a notification system that ensures timely communication through push notifications, SMS, or emails. Committed to maintaining high security and compliance standards, Mahalo follows regulations such as HIPAA, GCP, ISO27001, and GDPR. Its extensive range of services encompasses multiple therapeutic areas, including diabetes, cognitive health, cardiovascular issues, musculoskeletal conditions, mental health, oncology, rare diseases, and nonalcoholic steatohepatitis (NASH). Additionally, Mahalo Health empowers healthcare providers with tools to enhance patient engagement and outcomes through its innovative digital solutions.

REDCap Cloud serves as a comprehensive data-science platform that empowers organizations to gather, integrate, standardize, analyze, and disseminate clinical and research data that meets real-world and regulatory standards, all within a cohesive, standards-driven system. This platform facilitates the complete lifecycle of randomized clinical trials and real-world evidence research by providing diverse modules tailored for intricate trial design and execution, a centralized clinical data hub that integrates both eCRF and non-eCRF sources, AI/ML capabilities for real-time operational and data insights, and seamless connectivity to eSource and EHR systems. Additionally, it enhances patient engagement through tools like ePRO/eCOA and wearable devices, accommodating both hybrid and decentralized trial models. The analytics features include options for synthetic control arms and digital twins, ensuring adherence to global security compliance standards. Ultimately, REDCap Cloud is designed to mitigate data silos, eliminate vendor fragmentation, facilitate bidirectional data flows, and offer sponsors, CROs, and health systems comprehensive visibility and oversight regarding site performance, study data integrity, and regulatory preparedness. By streamlining these processes, organizations can achieve greater efficiency and effectiveness in their research endeavors.

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.

ClinSoft™, was developed in-house by Innovate Research. There were no third-party acquisitions and integrations. The system is compliant to FDA regulations (21 CFR Part 11, as well as GCP and HIPAA. The system is fully auditable and validated. ClinSoft™, which is easy to use, ensures quick start-ups and close-outs. This saves you precious time and allows you to be certain that any mid-study amendments or updates to protocols will be made promptly. Innovate Research, an Indian contract research company, provides services in clinical research and regulatory affairs. US FDA 21 CFR Part 11 compliant. Electronic Signatures & Records Secure, Role-Based Access. Audit Trail. Easy to use interface for Edit Checks and CRF Set-up. Frameworks that can be reused for item, panel, visit, and page.

Enhance the efficiency of regulatory operations within your organization to bolster compliance and facilitate research advancements. Veeva SiteVault simplifies the process of managing clinical trials by integrating your regulatory tasks, leading to improved effectiveness and adherence to regulations. You can oversee regulatory and source documents through a unified platform that complies with 21 CFR Part 11 and HIPAA standards. With real-time insights across all trials, SiteVault Enterprise boosts operational effectiveness, accelerates study initiation, and fosters swift, high-quality trial management. Transition away from manual workflows and customize your own processes to enhance both quality and speed in study activation. By granting monitors secure, direct access to your regulatory and source documents, you eliminate the hassles of EMR access and document redaction. Furthermore, you can tailor your workflows, generate reports, and create dashboards to gain deeper insights into start-up timelines and regulatory workflows, ultimately driving better outcomes for your clinical trials. This comprehensive approach not only streamlines processes but also enhances collaboration across teams.

SiteCentric is an integrated platform designed for clinical trial management, specifically created by research sites to address their unique needs, which combines various functions such as CRM, eISF, CTMS, financial management, and reporting into one cohesive system. This comprehensive solution streamlines and automates processes throughout the entire trial lifecycle, facilitating the nurturing of study leads and organization of pipeline activities with a specialized CRM. It also centralizes essential documents, including budgets, contracts, eReg, training records, and source documentation, to ensure a swift startup process. Additionally, it enhances enrollment efforts through targeted outreach strategies and by utilizing existing databases for more effective recruitment. The platform tracks patient visits meticulously while capturing high-quality eSource data, and conducts internal quality control checks along with maintaining version control and audit-ready eISF documentation. Furthermore, it oversees financial aspects such as budgets, invoicing, payment reconciliation, and patient reimbursements, while also providing leadership dashboards that reveal key performance metrics and trends in real-time, allowing research sites to make informed decisions quickly. Ultimately, SiteCentric empowers research sites by consolidating various functionalities into one efficient platform tailored to enhance clinical trial operations significantly.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

Experience the forefront of eSource, CTMS, and eRegulatory software designed specifically for clinical trial sites. With CRIO’s top-tier electronic source, you can effortlessly capture source data in real-time, drastically cutting down on paper usage by up to 90% while enhancing data quality by 80%. Gain command over your operations through CRIO’s user-friendly Clinical Trial Management System, allowing you to efficiently schedule patients, monitor financials, and optimize recruiting processes. We proudly present cutting-edge electronic regulatory binders, including the innovative first-ever electronic delegation log, all compliant with 21 CFR Part 11 standards. For clinical trial sponsors, you can perform 100% remote monitoring of your sites’ source data and regulatory documents through a secure online portal. Become a part of our extensive network of over 500 clinical research sites worldwide. Our commitment is to facilitate the growth of your business by streamlining your site’s operations, ensuring that your studies can continue smoothly, regardless of whether you're on-site or not. This way, you can focus on what truly matters: advancing your clinical research initiatives.

cubeCTMS is an all-encompassing clinical-trial management platform that facilitates complete oversight of trials, encompassing aspects such as tracking study sites and investigators, managing enrollment and visit schedules, and overseeing budget and contract workflows, as well as milestone reporting and document management. By centralizing study operations and automating essential processes, it allows sponsors, CROs, and study teams to oversee progress in real time, coordinate tasks across various studies, enhance communication with sites, and reduce risks. The platform offers integrated dashboards, notifications, and audit-ready documentation to ensure compliance with regulatory standards, including readiness for FDA 21 CFR Part 11, empowering stakeholders to oversee trial timelines, resources, and overall performance from a singular interface. Additionally, cubeCTMS seamlessly connects with other CRScube modules, such as EDC, eTMF, and pharmacy/RTSM, creating a cohesive ecosystem that minimizes redundancy, optimizes data flow, and supports flexible workflows during amendments or large-scale implementations. This integration not only streamlines processes but also enhances the overall efficiency of clinical trials, making it an invaluable tool for research teams.

Mosio allows research teams to improve subject adhesion, communications, data collection, and communication on mobile's most popular channel, text messaging. Our software helps research teams communicate more efficiently with participants by delivering interactive elements to mobile phones and messaging automation. WHO CAN WE HELP? + Clinical Trial Sponsors (Pharma & Biotech) + Cancer Centers and Clinical Research Organizations + NIH-Funded Studies + Public Health Agencies + Clinical Trial Managers/Directors and Clinical Operations Managers/Directors. Clinical Project Managers. Principal Investigators. Clinical Research (Study). Coordinators. All research staff who regularly communicate with study participants. BENEFITS + Interactive medication reminders and medication compliance alerts + Automate data collection. + Increase engagement and adherence. + Get SMS appointment reminders to fix your no-show problem. + Increase retention with automated check ins

Koneksa stands out as a prominent digital biomarker firm catering to the pharmaceutical and biotechnology sectors, focusing on the creation, testing, and validation of digital biomarkers that assist clients in assessing how treatments affect patients. Established in 2013, Koneksa delivers comprehensive remote clinical trial support by integrating digital health technologies, therapeutic knowledge, and swift, user-friendly remote data gathering to enhance understanding of patient health outcomes. Their innovative and validated data algorithms are designed for immediate use in treatment development initiatives, facilitating the detection of signals more rapidly than conventional methods. The company's cloud-based Software as a Service (SaaS) platform enables real-time integration of multiple endpoints, providing instant access to data and supporting informed, cost-effective decision-making early in the trial process. Additionally, this platform’s capability to gather extensive remote data at higher frequencies presents opportunities for obtaining ecologically valid measures, which can lead to a reduction in sample size while maintaining the integrity of the research. By continuously evolving their tools and methodologies, Koneksa aims to redefine how clinical trials are conducted in the modern age.

When compared to other Electronic Data Capture (EDC) solutions available from companies like MediData, DataTrack, and Omnicomm, TrialStat stands out as the most comprehensive suite of study management tools that can effortlessly integrate with various external data sources, including electronic medical records (EMR), wearable devices, and both clinical and non-clinical information systems. TrialStat presents a cohesive platform that caters to all phases and categories of clinical trials. Our EDC suite is designed with a single sign-on feature and supports multiple tenants, incorporating modules for Randomization, Adjudication, Coding, Safety, Patient Diaries/ePRO, a Vendor Neutral Imaging Archive, an extensive Reporting and Analytics Portal, and tailored Machine Learning applications. With an emphasis on data analysis, TrialStat provides real-time reporting capabilities, on-demand data extracts, and analytics that span a single study, a program, or the entirety of your research portfolio, ensuring that all stakeholders receive pertinent, customized, and timely insights into every facet of study data while pinpointing areas of risk or potential delays. Additionally, the platform’s integration capabilities allow for improved collaboration among research teams, fostering a more efficient and effective trial management experience.

Folio3 Digital Health offers an all-encompassing Clinical Trial Management Software (CTMS) that is a web-based solution aimed at enhancing the efficiency of the entire clinical trial lifecycle for pharmaceutical firms, contract research organizations (CROs), and research institutions. This platform consolidates various trial operations, facilitating everything from planning and site oversight to data gathering and reporting, while ensuring adherence to international regulations such as FDA 21 CFR Part 11, GxP, and HIPAA. With a focus on delivering user-friendly interface designs, real-time dashboards, and adaptable modules, the software is capable of managing clinical trials of any scale effectively. The system includes specialized modules for study initiation, allowing users to outline protocols, timelines, and budgets using customizable templates tailored to their needs. Moreover, the site management features enable tracking of investigator credentials, contracts, and financial transactions, in addition to patient recruitment tools that streamline screening, monitoring of enrollment, and scheduling of visits, complete with automated reminders to enhance participant engagement. Notably, the platform’s versatility makes it suitable for various stakeholders involved in clinical research, thereby promoting a more integrated and efficient trial management experience.

Research teams are facing rising demands to achieve greater outcomes with limited resources. The progress of a trial can be significantly hindered by issues such as disconnected systems, the necessity for manual data entry, repetitive workflows, and fragmented information. Thus, it is essential to adopt a clinical trial management system that integrates and optimizes workflows while ensuring complete transparency, and Medidata offers the perfect solution. Rave CTMS stands out as the sole data-centric platform designed for efficient and intelligent end-to-end trial management. As a key component of the Medidata Rave Clinical CloudTM, it encompasses all the features you would expect from a top-tier CTMS and even more. Rave CTMS empowers your study teams to plan and oversee all clinical trials consistently and cohesively, standardizing activity planning and management across study, country, and site levels. This includes managing the creation and activation of study/site teams, tracking patient enrollment and milestones, monitoring sites, and addressing issues effectively. Moreover, with Rave CTMS, you can enhance collaboration and communication among team members, which ultimately leads to better trial outcomes.

LabRelations is an innovative and adaptable laboratory platform designed to consolidate and optimize scientific and testing workflows by integrating essential modules like LIMS, ELN, CTMS, and EDC into a cohesive system that facilitates everything from sample tracking and experiment logging to study oversight and compliance reporting. This comprehensive tool not only minimizes manual tasks, inaccuracies, and data fragmentation but also allows laboratories to house all their information in one centralized location. Users can establish rule-based workflows and automations, link instruments and outside systems, as well as ensure complete audit trails and adherence to regulations such as GxP and 21 CFR. Furthermore, LabRelations provides the flexibility to tailor objects, forms, views, and permissions to meet the unique requirements of each lab, thereby enhancing collaboration across various functions and offering real-time insights spanning from research and quality assurance to clinical studies and highly regulated settings. As a result, this platform significantly elevates the efficiency and reliability of laboratory operations.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

Streamline your document workflows to eliminate inefficiencies that consume valuable time and resources, hindering your growth and ability to secure new studies. Florence eBinders seamlessly connects all your clinical trial systems, automates eRegulatory tasks, shortens contract negotiation duration, monitors study advancement, and facilitates secure remote oversight on a leading eRegulatory, eISF, and eSource platform. With our highly-rated implementation and support teams, your team and study can be set up quickly, ensuring a smooth transition for all users. Most sites become fully operational within just four weeks! By enabling secure access for your monitors and providing remote capabilities for your team, you can significantly decrease the time spent on-site during monitoring visits. Additionally, this approach fosters a more efficient and flexible research environment.

Longboat is a cloud-based solution designed to support clinical trials, offering an integrated Guided Compliance toolset that assists users consistently throughout the process. By supplying clinical trial site personnel with essential resources, Longboat enables them to concentrate on patient care. Additionally, it allows participants to access vital study details and receive reminders for upcoming visits. The platform facilitates the streamlined management of any amendments to the clinical trial protocol, ensuring a smooth and controlled rollout. Furthermore, it centralizes the secure sharing of regulated documents among sponsors, CROs, and sites, which significantly enhances the startup process and simplifies traditionally labor-intensive tasks for all research stakeholders. Through a unified support platform, all key participants—including clinical operations teams, monitors, site personnel, and trial participants—can access customized content that addresses their individual requirements. This comprehensive approach ensures that site staff are equipped with the necessary tools and resources to remain engaged and compliant while prioritizing the needs of participants. In doing so, Longboat not only improves operational efficiency but also elevates the overall experience for everyone involved in the clinical trial.

Modern Interactive Response Technology (IRT) systems are becoming more intricate. The significance of flexible and customizable IRT cannot be overstated, as this technology serves as the primary source for essential data, including recruitment metrics, clinical trial attrition rates, patient attendance, and more. It is vital to select a platform that is intuitive, optimized for mobile use, and all-encompassing—underpinned by high standards of quality, adaptability, and expertise. Embrace a partnership that offers profound therapeutic knowledge tailored to the contemporary risk-based eClinical landscape. By merging advanced technology with specialized knowledge and a dedication to exceptional service, we enhance clinical trials to achieve favorable patient results. Our extensive understanding of clinical processes and supply chain dynamics fosters innovation, granting clients greater control over their Randomization and Trial Supply Management (RTSM) protocols. Our cutting-edge tools elevate quality assurance, improve site productivity, and enhance patient adherence significantly. Furthermore, our IRT platform is adaptable enough to cater to a wide array of studies, with the capability for full validation and deployment in just 30 days, ensuring efficiency in clinical trial operations. This swift implementation can lead to more timely data collection and improved overall trial management.

CIMS Global delivers advanced data science platforms and eClinical solutions that are set to transform the landscape of clinical trials by enhancing the quality, efficiency, and speed of processes like data acquisition, processing, analysis, monitoring, and regulatory submissions. Their offerings feature groundbreaking tools such as CRE, DDM, DMC-HUB, and eBinder, as well as a comprehensive eClinical Suite that facilitates data collection, analytics, and clinical functions throughout all phases of a trial. CRE serves as a multi-tenant, validated Statistical Computing Environment specifically designed for compliant analysis of clinical data, leveraging R, RShiny, and the RStudio IDE within a secure framework ready for audits that aligns with 21 CFR Part 11 and GxP regulations. DDM stands out as a patented Dynamic Data Monitoring platform that visualizes cumulative treatment effects on a trial radar screen while also forecasting the likelihood of a trial’s success or failure. Additionally, the integration of these innovative solutions positions CIMS Global at the forefront of clinical trial technology, ensuring that researchers can achieve optimal outcomes in their studies.

Clin'form is an adaptable and powerful electronic Clinical Outcome Assessment (eCOA) platform that aims to simplify clinical trials for both patients and research sites, improve data integrity, and speed up processes for research teams. Its versatility allows it to be used across various protocols and demographics, making it suitable for any type of questionnaire—including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries—while catering to individuals of all ages, from children to the elderly. The platform is designed to handle diverse population sizes, effectively managing studies that involve anywhere from a small group to over 10,000 participants spread across multiple regions worldwide. Clin'form integrates smoothly with other clinical systems to provide an efficient workflow, supporting various data collection methods such as dedicated tablets or smartphones, the patient's personal device, web access on any browser, and in-person interviews. Noteworthy features include an integrated tele-visit option to accommodate unexpected changes and patient engagement tools that promote high levels of compliance. Additionally, Clin'form's user-friendly interface ensures that both researchers and participants can easily navigate the platform, making the clinical trial experience more streamlined and effective.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

Data MATRIX offers a comprehensive SaaS solution specifically designed for clinical trials. Since its inception in 2009, the Data MATRIX team has specialized in the processing and analysis of clinical data, creating documents that comply with the standards set by the Russian Ministry of Health, FDA, and EMA. Our software streamlines clinical trial processes, allowing users to efficiently manage and track progress online. Before launching a project, we meticulously adjust and validate our software to ensure that every aspect is considered for optimal performance. With a proven track record of completing 180 projects for pharmaceutical companies, biotech firms, and CROs, our solutions have led 6 out of the top 10 Big Pharma companies to achieve a 15% reduction in R&D expenses. Our dedicated team members take pride in their involvement with professional organizations that connect clinical data professionals such as CDISC, ACDM, SCDM, biostatisticians like ISBC, and medical writers associated with EMWA and AMWA. By continually enhancing our offerings, we remain committed to driving innovation in the clinical research landscape.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

With more than two decades of expertise in the fields of software publishing and clinical research, Arone delivers a comprehensive array of tools designed for the efficient entry and management of patient data for clinical research organizations. Our solutions are ready to use, and we offer tailored support to ensure your projects and studies are conducted effectively. Utilize a unified platform to gather and oversee patient data seamlessly. Arone facilitates patient randomization by randomly designating treatment types to study participants, which helps eliminate bias in research outcomes. Enhance the engagement of clinical trial participants by enabling them to enter their daily data conveniently. Additionally, our personalized support enhances the overall success of your research projects. Together, we strive to innovate and improve the clinical research landscape.

Clinical One RTSM is capable of accommodating various randomization strategies, ranging from the most straightforward to highly intricate studies, all without requiring any programming or coding, which consequently reduces the duration of user acceptance testing. You can take charge of your study with self-service configurations, allowing you to develop a study in just a matter of days rather than weeks. Additionally, you can assess the drug inventory status and make real-time adjustments without needing to consult the vendor, thereby avoiding unnecessary costs and change requests. By implementing changes swiftly, you can eliminate expenses associated with change requests and prevent delays, enabling you to launch your studies almost instantaneously. This platform stands out as the only one that genuinely integrates individuals, processes, and data to streamline and expedite the future of clinical trials. Moreover, the inclusion of virtual components in clinical trials enhances patient engagement and significantly elevates the quality of trial data. To keep pace with the rapidly evolving landscape, it is essential to adopt transformative digital strategies that facilitate quicker study initiations, harmonize data from diverse sources, and optimize workflow efficiency. Such advancements are pivotal for the successful execution of modern clinical research initiatives.

We offer a comprehensive tracking solution designed specifically for clinical trials. With a simple download onto your trial managers' mobile devices, you can relax as TruLab's advanced blockchain technology handles all the complexities. There's no need to wait for samples to arrive at a central lab to identify potential issues; instead, you can detect data anomalies in real-time as samples progress through the clinical trial process. TruLab facilitates continual remote accessioning of samples, addressing the significant concern that 20% of samples are either lost or deemed unusable during late-stage trials. This situation is unacceptable from ethical, logistical, and financial perspectives. Furthermore, with sample collections increasingly taking place at participants' homes, new challenges in tracking these samples arise. TruLab effectively monitors samples wherever they are located, ensuring that they are accounted for from residences to repositories, thus enhancing the overall integrity of the clinical trial process. By providing seamless tracking capabilities, TruLab empowers trial managers to mitigate risks and improve outcomes.

Effectively monitor clinical trials from start to finish with Ennov’s comprehensive Clinical Trial Management software. Each year, clinical trial sponsors search for new ways to improve the efficiency and reduce the costs associated with running their trials. Investigational site efficiency and productivity can be improved by centralizing information, actively monitoring progress, automating schedules, managing finances, and providing accurate reporting and metrics. With the Ennov CTMS, trial sponsors and CROs are able to actively address all aspects of trial management from a single platform: investigator sites, patients, SAEs, deviations, inclusions, visit reports, phone contacts, investigational product management, trial facilities, and finances. Study managers can plan and track their trials in real time to make better decisions faster. With the Ennov CTMS dashboard functionality, study personnel get on-demand analytics to improve quality, control risk, and reduce costs.

Cloudbyz CTMS is a cloud-based trial management platform natively built on Salesforce Cloud. It is aimed at sponsors, clinical research organizations (CRO), and clinical sites for managing end-to-end clinical trial operations. Designed for clinical research, it expedites implementation and drives user adoption. Cloudbyz CTMS comes with an intuitive, straightforward design that allows for quick deployment. Boasting a rich set of features, Cloudbyz CTMS makes it easy for users to manage all aspects of clinical trials, including sites, enrolment, documents, events, milestones, site visit reports, finances, inventory, etc. The solution benefits are listed below- 1. Secure, reliable & scalable 2. Faster time to value 3. Monitor study progress & risks from planning to close-out 4. Seamless collaboration among sponsors, CROs & sites 5. Improved clinical team efficiency

BioGRID serves as an advanced clinical data management platform and visual analytics solution aimed at simplifying the handling of clinical data while enhancing the decision-making process. By integrating cutting-edge AI technology with user-friendly visualizations, robust compliance features, and efficient workflows for clinical trials, it creates a cohesive environment. This tool consolidates a variety of clinical data sources, allowing for uninterrupted data ingestion, trend identification, forecasting, and predictive analytics that assist teams in recognizing patterns and potential risks, thus fostering proactive decision-making. Additionally, BioGRID offers thorough oversight of studies, providing comprehensive views of both progress and outcomes, along with automated patient tracking systems and resources for effective medical and statistical evaluations. It also incorporates proactive data surveillance and risk-based quality management capabilities, which help maintain data integrity and compliance with industry regulations, including the monitoring of key risk indicators, identifying possible discrepancies, and maintaining audit trails. Ultimately, BioGRID empowers clinical teams to navigate complex data landscapes with confidence and precision.

Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.

Ripple, a web-based software solution that allows for the management and recruitment of research participants in clinical, translational, and social science studies is an active registry. Ripple was developed by researchers to transform the participant workflow. It is an end-to–end research participant management system that speeds up the entire research process.

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.